CompletedNot Applicable

Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes

United States109 participantsStarted 2016-02-01

Plain-language summary

The purpose of this study is to investigate the effects of a combined vitamin D and magnesium supplementation on parathyroid hormone and cardiometabolic health in persons living with obesity.

Who can participate

Age range30 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * BMI range 25-40 kg/m2 * 30-70 years of age Exclusion Criteria: * Presence of any acute illness in the past month * Pre-existing chronic medical conditions or medications know to influence energy, vitamin D, magnesium and calcium metabolism, levels of blood glucose, lipids and blood pressure * Individuals taking vitamin D and magnesium supplement greater than the Recommended Daily allowance * Participants taking any medications or have disease known to influence calcium or bone metabolism

What they're measuring

Serum parathyroid hormone

Timeframe: 12 weeks

Trial details

NCT IDNCT03134417

SponsorDrexel University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Overweight and Obesity trials